Global Tuberculosis Diagnostic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 20-Sep-2022
No. of pages: 109
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Tuberculosis Diagnostic companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Tuberculosis Diagnostic market. Further, it explains the major drivers and regional dynamics of the global Tuberculosis Diagnostic market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Thermo Fisher Scientific

- Hologic Corporation

- Abbott

- Becton Dickinson

- Roche

- bioMerieux

- Sanofi

- Cepheid

- Hain Lifescience

- QIAGEN

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Tuberculosis Diagnostic Segment by Type

- Radiographic Method

- Diagnostic Laboratory Methods

- Nucleic Acid Testing

- Phage Assay

- Detection of Latent Infection

- Cytokine Detection Assay

- Detection of Drug Resistance

Tuberculosis Diagnostic Segment by Application

- Infants

- Adults

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Tuberculosis Diagnostic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Tuberculosis Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Tuberculosis Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Tuberculosis Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tuberculosis Diagnostic revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Tuberculosis Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Tuberculosis Diagnostic revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Hologic Corporation, Abbott, Becton Dickinson, Roche, bioMerieux, Sanofi, Cepheid and Hain Lifescience, etc.

Global Tuberculosis Diagnostic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Radiographic Method
1.2.3 Diagnostic Laboratory Methods
1.2.4 Nucleic Acid Testing
1.2.5 Phage Assay
1.2.6 Detection of Latent Infection
1.2.7 Cytokine Detection Assay
1.2.8 Detection of Drug Resistance
1.3 Market by Application
1.3.1 Global Tuberculosis Diagnostic Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Infants
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Tuberculosis Diagnostic Market Size (2017-2028)
2.2 Tuberculosis Diagnostic Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Tuberculosis Diagnostic Market Size by Region (2017-2022)
2.4 Global Tuberculosis Diagnostic Market Size Forecast by Region (2023-2028)
2.5 Global Top Tuberculosis Diagnostic Countries Ranking by Market Size
3 Tuberculosis Diagnostic Competitive by Company
3.1 Global Tuberculosis Diagnostic Revenue by Players
3.1.1 Global Tuberculosis Diagnostic Revenue by Players (2017-2022)
3.1.2 Global Tuberculosis Diagnostic Market Share by Players (2017-2022)
3.2 Global Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Tuberculosis Diagnostic Revenue
3.4 Global Tuberculosis Diagnostic Market Concentration Ratio
3.4.1 Global Tuberculosis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostic Revenue in 2021
3.5 Global Tuberculosis Diagnostic Key Players Head office and Area Served
3.6 Key Players Tuberculosis Diagnostic Product Solution and Service
3.7 Date of Enter into Tuberculosis Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Tuberculosis Diagnostic Breakdown Data by Type
4.1 Global Tuberculosis Diagnostic Historic Revenue by Type (2017-2022)
4.2 Global Tuberculosis Diagnostic Forecasted Revenue by Type (2023-2028)
5 Global Tuberculosis Diagnostic Breakdown Data by Application
5.1 Global Tuberculosis Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Tuberculosis Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tuberculosis Diagnostic Revenue by Company (2020-2022)
6.2 North America Tuberculosis Diagnostic Revenue by Type (2017-2028)
6.3 North America Tuberculosis Diagnostic Revenue by Application (2017-2028)
6.4 North America Tuberculosis Diagnostic Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Tuberculosis Diagnostic Revenue by Company (2020-2022)
7.2 Europe Tuberculosis Diagnostic Revenue by Type (2017-2028)
7.3 Europe Tuberculosis Diagnostic Revenue by Application (2017-2028)
7.4 Europe Tuberculosis Diagnostic Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Tuberculosis Diagnostic Revenue by Company (2020-2022)
8.2 Asia Pacific Tuberculosis Diagnostic Revenue by Type (2017-2028)
8.3 Asia Pacific Tuberculosis Diagnostic Revenue by Application (2017-2028)
8.4 Asia Pacific Tuberculosis Diagnostic Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Tuberculosis Diagnostic Revenue by Company (2020-2022)
9.2 Latin America Tuberculosis Diagnostic Revenue by Type (2017-2028)
9.3 Latin America Tuberculosis Diagnostic Revenue by Application (2017-2028)
9.4 Latin America Tuberculosis Diagnostic Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Tuberculosis Diagnostic Revenue by Company (2020-2022)
10.2 Middle East and Africa Tuberculosis Diagnostic Revenue by Type (2017-2028)
10.3 Middle East and Africa Tuberculosis Diagnostic Revenue by Application (2017-2028)
10.4 Middle East and Africa Tuberculosis Diagnostic Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Products and Services
11.1.4 Thermo Fisher Scientific Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.1.5 Thermo Fisher Scientific Tuberculosis Diagnostic SWOT Analysis
11.1.6 Thermo Fisher Scientific Recent Developments
11.2 Hologic Corporation
11.2.1 Hologic Corporation Company Details
11.2.2 Hologic Corporation Business Overview
11.2.3 Hologic Corporation Tuberculosis Diagnostic Products and Services
11.2.4 Hologic Corporation Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.2.5 Hologic Corporation Tuberculosis Diagnostic SWOT Analysis
11.2.6 Hologic Corporation Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Tuberculosis Diagnostic Products and Services
11.3.4 Abbott Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.3.5 Abbott Tuberculosis Diagnostic SWOT Analysis
11.3.6 Abbott Recent Developments
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Details
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson Tuberculosis Diagnostic Products and Services
11.4.4 Becton Dickinson Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.4.5 Becton Dickinson Tuberculosis Diagnostic SWOT Analysis
11.4.6 Becton Dickinson Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Tuberculosis Diagnostic Products and Services
11.5.4 Roche Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.5.5 Roche Tuberculosis Diagnostic SWOT Analysis
11.5.6 Roche Recent Developments
11.6 bioMerieux
11.6.1 bioMerieux Company Details
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux Tuberculosis Diagnostic Products and Services
11.6.4 bioMerieux Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.6.5 bioMerieux Tuberculosis Diagnostic SWOT Analysis
11.6.6 bioMerieux Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Tuberculosis Diagnostic Products and Services
11.7.4 Sanofi Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.7.5 Sanofi Tuberculosis Diagnostic SWOT Analysis
11.7.6 Sanofi Recent Developments
11.8 Cepheid
11.8.1 Cepheid Company Details
11.8.2 Cepheid Business Overview
11.8.3 Cepheid Tuberculosis Diagnostic Products and Services
11.8.4 Cepheid Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.8.5 Cepheid Tuberculosis Diagnostic SWOT Analysis
11.8.6 Cepheid Recent Developments
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Details
11.9.2 Hain Lifescience Business Overview
11.9.3 Hain Lifescience Tuberculosis Diagnostic Products and Services
11.9.4 Hain Lifescience Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.9.5 Hain Lifescience Tuberculosis Diagnostic SWOT Analysis
11.9.6 Hain Lifescience Recent Developments
11.10 QIAGEN
11.10.1 QIAGEN Company Details
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Tuberculosis Diagnostic Products and Services
11.10.4 QIAGEN Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022)
11.10.5 QIAGEN Tuberculosis Diagnostic SWOT Analysis
11.10.6 QIAGEN Recent Developments
12 Tuberculosis Diagnostic Market Dynamics
12.1 Tuberculosis Diagnostic Market Trends
12.2 Tuberculosis Diagnostic Market Drivers
12.3 Tuberculosis Diagnostic Market Challenges
12.4 Tuberculosis Diagnostic Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Tuberculosis Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Radiographic Method
Table 3. Key Players of Diagnostic Laboratory Methods
Table 4. Key Players of Nucleic Acid Testing
Table 5. Key Players of Phage Assay
Table 6. Key Players of Detection of Latent Infection
Table 7. Key Players of Cytokine Detection Assay
Table 8. Key Players of Detection of Drug Resistance
Table 9. Global Tuberculosis Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Tuberculosis Diagnostic Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 11. Global Tuberculosis Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Tuberculosis Diagnostic Revenue Market Share by Region (2017-2022)
Table 13. Global Tuberculosis Diagnostic Revenue by Players (2017-2022) & (US$ Million)
Table 14. Global Tuberculosis Diagnostic Market Share by Players (2017-2022)
Table 15. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2021)
Table 16. Ranking of Global Top Tuberculosis Diagnostic Companies by Revenue (US$ Million) in 2021
Table 17. Global 5 Largest Players Market Share by Tuberculosis Diagnostic Revenue (CR5 and HHI) & (2017-2022)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Tuberculosis Diagnostic Product Solution and Service
Table 20. Date of Key Manufacturers Enter into Tuberculosis Diagnostic Market
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Tuberculosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 23. Global Tuberculosis Diagnostic Revenue Market Share by Type (2017-2022)
Table 24. Global Tuberculosis Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 25. Global Tuberculosis Diagnostic Revenue Market Share by Type (2023-2028)
Table 26. Global Tuberculosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 27. Global Tuberculosis Diagnostic Revenue Market Share by Application (2017-2022)
Table 28. Global Tuberculosis Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 29. Global Tuberculosis Diagnostic Revenue Market Share by Application (2023-2028)
Table 30. North America Tuberculosis Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 31. North America Tuberculosis Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 32. North America Tuberculosis Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 33. North America Tuberculosis Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 34. North America Tuberculosis Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 35. North America Tuberculosis Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 36. North America Tuberculosis Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 37. Europe Tuberculosis Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 38. Europe Tuberculosis Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 39. Europe Tuberculosis Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 40. Europe Tuberculosis Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 41. Europe Tuberculosis Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 42. Europe Tuberculosis Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 43. Europe Tuberculosis Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Tuberculosis Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 45. Asia Pacific Tuberculosis Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Tuberculosis Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Tuberculosis Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Tuberculosis Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Tuberculosis Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Tuberculosis Diagnostic Revenue by Region (2023-2028) & (US$ Million)
Table 51. Latin America Tuberculosis Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 52. Latin America Tuberculosis Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 53. Latin America Tuberculosis Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 54. Latin America Tuberculosis Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 55. Latin America Tuberculosis Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 56. Latin America Tuberculosis Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 57. Latin America Tuberculosis Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Tuberculosis Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 59. Middle East and Africa Tuberculosis Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Tuberculosis Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Tuberculosis Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Tuberculosis Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Tuberculosis Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Tuberculosis Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 65. Thermo Fisher Scientific Company Details
Table 66. Thermo Fisher Scientific Business Overview
Table 67. Thermo Fisher Scientific Tuberculosis Diagnostic Product and Services
Table 68. Thermo Fisher Scientific Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 69. Thermo Fisher Scientific Tuberculosis Diagnostic SWOT Analysis
Table 70. Thermo Fisher Scientific Recent Developments
Table 71. Hologic Corporation Company Details
Table 72. Hologic Corporation Business Overview
Table 73. Hologic Corporation Tuberculosis Diagnostic Product and Services
Table 74. Hologic Corporation Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 75. Hologic Corporation Tuberculosis Diagnostic SWOT Analysis
Table 76. Hologic Corporation Recent Developments
Table 77. Abbott Company Details
Table 78. Abbott Business Overview
Table 79. Abbott Tuberculosis Diagnostic Product and Services
Table 80. Abbott Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 81. Abbott Tuberculosis Diagnostic SWOT Analysis
Table 82. Abbott Recent Developments
Table 83. Becton Dickinson Company Details
Table 84. Becton Dickinson Business Overview
Table 85. Becton Dickinson Tuberculosis Diagnostic Product and Services
Table 86. Becton Dickinson Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 87. Becton Dickinson Tuberculosis Diagnostic SWOT Analysis
Table 88. Becton Dickinson Recent Developments
Table 89. Roche Company Details
Table 90. Roche Business Overview
Table 91. Roche Tuberculosis Diagnostic Product and Services
Table 92. Roche Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 93. Roche Tuberculosis Diagnostic SWOT Analysis
Table 94. Roche Recent Developments
Table 95. bioMerieux Company Details
Table 96. bioMerieux Business Overview
Table 97. bioMerieux Tuberculosis Diagnostic Product and Services
Table 98. bioMerieux Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 99. bioMerieux Tuberculosis Diagnostic SWOT Analysis
Table 100. bioMerieux Recent Developments
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Tuberculosis Diagnostic Product and Services
Table 104. Sanofi Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 105. Sanofi Tuberculosis Diagnostic SWOT Analysis
Table 106. Sanofi Recent Developments
Table 107. Cepheid Company Details
Table 108. Cepheid Business Overview
Table 109. Cepheid Tuberculosis Diagnostic Product and Services
Table 110. Cepheid Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 111. Cepheid Tuberculosis Diagnostic SWOT Analysis
Table 112. Cepheid Recent Developments
Table 113. Hain Lifescience Company Details
Table 114. Hain Lifescience Business Overview
Table 115. Hain Lifescience Tuberculosis Diagnostic Product and Services
Table 116. Hain Lifescience Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 117. Hain Lifescience Tuberculosis Diagnostic SWOT Analysis
Table 118. Hain Lifescience Recent Developments
Table 119. QIAGEN Company Details
Table 120. QIAGEN Business Overview
Table 121. QIAGEN Tuberculosis Diagnostic Product and Services
Table 122. QIAGEN Tuberculosis Diagnostic Revenue in Tuberculosis Diagnostic Business (2017-2022) & (US$ Million)
Table 123. QIAGEN Tuberculosis Diagnostic SWOT Analysis
Table 124. QIAGEN Recent Developments
Table 125. Tuberculosis Diagnostic Market Trends
Table 126. Tuberculosis Diagnostic Market Drivers
Table 127. Tuberculosis Diagnostic Market Challenges
Table 128. Tuberculosis Diagnostic Market Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Diagnostic Sales Market Share by Type: 2021 VS 2028
Figure 2. Radiographic Method Features
Figure 3. Diagnostic Laboratory Methods Features
Figure 4. Nucleic Acid Testing Features
Figure 5. Phage Assay Features
Figure 6. Detection of Latent Infection Features
Figure 7. Cytokine Detection Assay Features
Figure 8. Detection of Drug Resistance Features
Figure 9. Global Tuberculosis Diagnostic Sales Market Share by Application: 2021 VS 2028
Figure 10. Infants Case Studies
Figure 11. Adults Case Studies
Figure 12. Tuberculosis Diagnostic Report Years Considered
Figure 13. Global Tuberculosis Diagnostic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Tuberculosis Diagnostic Market Size 2017-2028 (US$ Million)
Figure 15. Global Tuberculosis Diagnostic Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Tuberculosis Diagnostic Revenue Market Share by Region in 2017 VS 2022
Figure 17. Global Top 10 Tuberculosis Diagnostic Countries Ranking by Market Size (US$ Million) in 2021
Figure 18. Global Tuberculosis Diagnostic Market Share by Players in 2021
Figure 19. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostic Revenue in 2021
Figure 21. North America Tuberculosis Diagnostic Revenue Market Share by Company in 2021
Figure 22. North America Tuberculosis Diagnostic Revenue Market Share by Type (2017-2028)
Figure 23. North America Tuberculosis Diagnostic Revenue Market Share by Application (2017-2028)
Figure 24. North America Tuberculosis Diagnostic Revenue Share by Country (2017-2028)
Figure 25. U.S. Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 26. Canada Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 27. Europe Tuberculosis Diagnostic Revenue Market Share by Company in 2021
Figure 28. Europe Tuberculosis Diagnostic Revenue Market Share by Type (2017-2028)
Figure 29. Europe Tuberculosis Diagnostic Revenue Market Share by Application (2017-2028)
Figure 30. Europe Tuberculosis Diagnostic Revenue Share by Country (2017-2028)
Figure 31. Germany Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 32. France Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 33. U.K. Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 34. Italy Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 35. Russia Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Tuberculosis Diagnostic Revenue Market Share by Company in 2021
Figure 37. Asia Pacific Tuberculosis Diagnostic Revenue Market Share by Type (2017-2028)
Figure 38. Asia Pacific Tuberculosis Diagnostic Revenue Market Share by Application (2017-2028)
Figure 39. Asia Pacific Tuberculosis Diagnostic Revenue Share by Region (2017-2028)
Figure 40. China Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 41. Japan Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 42. South Korea Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 43. India Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 44. Australia Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 45. Taiwan Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 46. Indonesia Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 47. Thailand Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 48. Malaysia Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 49. Philippines Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 50. Vietnam Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 51. Latin America Tuberculosis Diagnostic Revenue Market Share by Company in 2021
Figure 52. Latin America Tuberculosis Diagnostic Revenue Market Share by Type (2017-2028)
Figure 53. Latin America Tuberculosis Diagnostic Revenue Market Share by Application (2017-2028)
Figure 54. Latin America Tuberculosis Diagnostic Revenue Share by Country (2017-2028)
Figure 55. Mexico Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 56. Brazil Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 57. Argentina Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 58. Middle East and Africa Tuberculosis Diagnostic Revenue Market Share by Company in 2021
Figure 59. Middle East and Africa Tuberculosis Diagnostic Revenue Market Share by Type (2017-2028)
Figure 60. Middle East and Africa Tuberculosis Diagnostic Revenue Market Share by Application (2017-2028)
Figure 61. Middle East and Africa Tuberculosis Diagnostic Revenue Share by Country (2017-2028)
Figure 62. Turkey Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 63. Saudi Arabia Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 64. U.A.E Tuberculosis Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 66. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 67. Abbott Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 68. Becton Dickinson Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 69. Roche Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 70. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 71. Sanofi Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 72. Cepheid Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 73. Hain Lifescience Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 74. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostic Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • Global Point of Care Diagnostic Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 26-Sep-2022        Price: US 5600 Onwards        Pages: 122
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Point of Care Diagnostic Devices manufacturers, distributors, end users, industry associations, governments' industry burea......
  • Global Point-of-Care Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 20-Sep-2022        Price: US 5600 Onwards        Pages: 113
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Point-of-Care Diagnostics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry......
  • Global POC HbA1C Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 20-Sep-2022        Price: US 5900 Onwards        Pages: 110
    HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes. HbA1c is your average blood glucose (sugar) levels for the last two to three months. The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for pr......
  • Global Tuberculosis Diagnostic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 20-Sep-2022        Price: US 5600 Onwards        Pages: 109
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Tuberculosis Diagnostic companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry e......
  • Global POC Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 16-Sep-2022        Price: US 5900 Onwards        Pages: 127
    Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global PO......
  • Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 07-Sep-2022        Price: US 5900 Onwards        Pages: 106
    Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night......
  • Global Tuberculosis (TB) Diagnostics Market Research Report 2022
    Published: 06-Sep-2022        Price: US 2900 Onwards        Pages: 87
    Tuberculosis (TB) Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Tuberculosis (TB) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Culture-Based Diagnostics - Sputum Smear Microscopy......
  • Global Point-of-Care Testing (POCT) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 05-Sep-2022        Price: US 5900 Onwards        Pages: 132
    Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Point-of-Care ......
  • Global Point-of-Care Testing (POCT) Market Research Report 2022
    Published: 05-Sep-2022        Price: US 2900 Onwards        Pages: 114
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Blood Glucose Testing - Infectious Diseases Testing - Cardiac Markers Testing - Coagulation Testing......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs